You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma

Showing 51 - 75 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Healthcare Resource Utilization and Costs of Immune Checkpoint

Completed
  • Melanoma
    • East Hanover, New Jersey
      Novartis
    May 12, 2023

    Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

    Recruiting
    • Melanoma
    • OH2
    • Salvage chemotherapy or best supportive care
    • Beijing, Beijing, China
    • +2 more
    May 11, 2023

    Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

    Not yet recruiting
    • Advanced Mucosal Melanoma
    • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
    • (no location specified)
    Sep 15, 2023

    Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

    Recruiting
    • Uveal Melanoma
    • +3 more
    • Lifileucel (LN-144)
    • Harrison, New York
    • +1 more
    Nov 8, 2022

    Melanoma and Vitiligo Trial in Nice (Biospecimen into patients who had skin diseases)

    Recruiting
    • Melanoma and Vitiligo
    • Biospecimen into patients who had skin diseases
    • Nice, Provence Alpes Cote d'Azur, France
      CHU de Nice
    Jan 23, 2023

    Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

    Active, not recruiting
    • Melanoma
      • Murray, Utah
      • +1 more
      Feb 17, 2023

      Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

      Recruiting
      • Melanoma (Skin)
      • Omsk, Russian Federation
      • +2 more
      Aug 1, 2023

      Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

      Not yet recruiting
      • Metastatic Melanoma
      • Skin Cancer
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Mar 9, 2023

      Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

      Recruiting
      • Melanoma Stage III
      • Melanoma Stage IV
      • San Francisco, California
        University of California, San Francisco
      Dec 6, 2022

      Melanoma Trial in Rotterdam (Nivolumab)

      Recruiting
      • Melanoma
      • Rotterdam, Pending, Netherlands
        Erasmus MC
      Oct 30, 2023

      Associated Factors, and Clinical Outcomes of Prescribing

      Completed
      • BRAF v600 Mutated Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Mar 28, 2023

        Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

        Active, not recruiting
        • Stage III Cutaneous Melanoma AJCC v7
        • +4 more
        • Cryosurgery
        • +3 more
        • Rochester, Minnesota
          Mayo Clinic
        Jan 3, 2023

        A Storage Facility for Tissues Obtained From Malignant Melanoma

        Recruiting
        • Melanoma
        • Biospecimen Collection
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 6, 2022

        Unmet Needs and Attitudes to Skin Self-examination in Melanoma

        Completed
        • Melanoma, Stage I
        • +2 more
        • Questionnaire
        • Headington, Oxford, United Kingdom
          Churchill Hospital
        Nov 19, 2022

        Melanoma Trial in Beijing (KD6001, Toripalimab)

        Not yet recruiting
        • Melanoma
        • Beijing, China
          Beijing Cancer Hospital
        Feb 3, 2023

        Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

        Active, not recruiting
        • Melanoma
        • Beijing City, China
        • +2 more
        Dec 13, 2022

        Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

        Not yet recruiting
        • Advanced Glioblastoma
        • +2 more
        • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
        • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
        • Ramat Gan, Israel
          Sheba medical center
        Jun 11, 2023

        Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

        Not yet recruiting
        • Advanced Uveal Melanoma
        • +2 more
        • BRD4 Inhibitor PLX2853
        • +4 more
        • (no location specified)
        Jan 9, 2023

        Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • +2 more
        • Marlborough, Massachusetts
          Phio Pharmaceuticals Corp.
        Aug 25, 2023

        Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

        Recruiting
        • Metastatic Melanoma
        • Lifileucel (LN-144)
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Jan 23, 2023

        Melanoma Trial in Houston (Fibrin Sealant)

        Completed
        Has Results
        • Melanoma
        • Fibrin Sealant
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Oct 20, 2022

        NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Melanoma
        • (no location specified)
        Jan 24, 2023

        Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

        Recruiting
        • Uveal Melanoma
        • Supportive care visit with questionnaires
        • Oncological standard visit
        • Nice, France
        • +1 more
        Jan 19, 2023

        Melanoma Trial ([U-13C]Glucose Infusion)

        Not yet recruiting
        • Melanoma
        • [U-13C]Glucose Infusion
        • (no location specified)
        Oct 6, 2022